Advertisement
Loading...

Stratec SE

STSEYPNK
Healthcare
Medical - Devices
$5.51
$0.00(0.00%)
U.S. Market opens in 11h 5m

Stratec SE Fundamental Analysis

Stratec SE (STSEY) shows weak financial fundamentals with a PE ratio of -5891.13, profit margin of -0.10%, and ROE of -0.10%. The company generates $0.3B in annual revenue with weak year-over-year growth of -1.64%.

Key Strengths

Current Ratio3.97

Areas of Concern

ROE-0.10%
Operating Margin4.26%
Cash Position1.46%
PEG Ratio68.84
We analyze STSEY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 22.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
22.6/100

We analyze STSEY's fundamental strength across five key dimensions:

Efficiency Score

Weak

STSEY struggles to generate sufficient returns from assets.

ROA > 10%
-0.06%

Valuation Score

Moderate

STSEY shows balanced valuation metrics.

PE < 25
-5891.13
PEG Ratio < 2
68.84

Growth Score

Weak

STSEY faces weak or negative growth trends.

Revenue Growth > 5%
-1.64%
EPS Growth > 10%
4.76%

Financial Health Score

Excellent

STSEY maintains a strong and stable balance sheet.

Debt/Equity < 1
0.56
Current Ratio > 1
3.97

Profitability Score

Weak

STSEY struggles to sustain strong margins.

ROE > 15%
-10.18%
Net Margin ≥ 15%
-0.10%
Positive Free Cash Flow
No

Key Financial Metrics

Is STSEY Expensive or Cheap?

P/E Ratio

STSEY trades at -5891.13 times earnings. This suggests potential undervaluation.

-5891.13

PEG Ratio

When adjusting for growth, STSEY's PEG of 68.84 indicates potential overvaluation.

68.84

Price to Book

The market values Stratec SE at 6.01 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

6.01

EV/EBITDA

Enterprise value stands at 38.97 times EBITDA. This signals the market has high growth expectations.

38.97

How Well Does STSEY Make Money?

Net Profit Margin

For every $100 in sales, Stratec SE keeps $-0.10 as profit after all expenses.

-0.10%

Operating Margin

Core operations generate 4.26 in profit for every $100 in revenue, before interest and taxes.

4.26%

ROE

Management delivers $-0.10 in profit for every $100 of shareholder equity.

-0.10%

ROA

Stratec SE generates $-0.06 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.06%

Following the Money - Real Cash Generation

Operating Cash Flow

Stratec SE generates limited operating cash flow of $-433.00K, signaling weaker underlying cash strength.

$-433.00K

Free Cash Flow

Stratec SE generates weak or negative free cash flow of $-12.78M, restricting financial flexibility.

$-12.78M

FCF Per Share

Each share generates $-0.04 in free cash annually.

$-0.04

FCF Yield

STSEY converts -0.90% of its market value into free cash.

-0.90%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5891.13

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

68.84

vs 25 benchmark

P/B Ratio

Price to book value ratio

6.007

vs 25 benchmark

P/S Ratio

Price to sales ratio

5.68

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.56

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.97

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.00

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

0.03

vs 25 benchmark

How STSEY Stacks Against Its Sector Peers

MetricSTSEY ValueSector AveragePerformance
P/E Ratio-5891.1329.24 Better (Cheaper)
ROE-0.10%713.00% Weak
Net Margin-0.10%-42604.00% (disorted) Weak
Debt/Equity0.560.46 Weak (High Leverage)
Current Ratio3.974.36 Strong Liquidity
ROA-0.06%-16668.00% (disorted) Weak

STSEY outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Stratec SE's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

14.67%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

9.45%

Industry Style: Defensive, Growth, Innovation

Growing

FCF CAGR

126.01%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ